Penile traction therapy (PTT) is a new therapeutic option for guys with Peyronie's disease (PD). Nonetheless, it has a long history of use in other medical fields, such as Dupuytren's, skeletal muscle, skin, and bone. Mechanotransduction, which is the progressive expansion of tissue by traction, causes cellular proliferation, which results in the production of new collagen tissue. Collagenase and metalloproteinases greatly increase as a result, causing the fibrous plaque to molecularly relax and expand over time.
Recent carefully planned experimental experiments have provided evidence to support this fictitious knowledge. Additionally, the use of PTT in PD patients has shown encouraging benefits in a number of clinical papers. The use of PTT considerably enhances flaccid and extended penile, according to various series lengths, and significantly improves penile curvature relative to baseline. Additionally, it has been demonstrated that using PTT concurrently with verapamil or interferon -2b is a successful treatment. Additionally, PTT has been shown to increase penile length in men with corporal fibrosis before or after penile surgery.
Finally, PTT use has demonstrated encouraging outcomes by a number of experts as a minimally invasive alternative therapy option to penile augmentation surgery in males with dysmorphophobia. Studies have revealed that PTT offers a suitable, less invasive treatment that can enlarge the penis in men who complain of having a small or short penis.
However, there are a number of issues with the reported studies' designs, including their tiny sample sizes. Bias in selection and size. However, to prove the full advantages of PTT, well-designed studies with bigger patient populations and longer follow-up times are required!
In the tunica albuginea, Peyronie's disease (PD) is characterized by the formation of a fibrous, inelastic scar that can cause penile deformity, curvature, shrinkage, narrowing, hinging, shortening, and painful erections. These symptoms then result in painful or uncomfortable sexual encounters (1-7).
Reassurance, as well as medicinal, mechanical, and surgical alternatives, are available as treatments (1). The early/acute stage of the disease is treated with medical treatments for PD patients. Despite several reports of penile curvature stabilization and/or improvement in other clinical symptoms in the literature, the recent guidelines state that the data suggests no appreciable benefit from using this treatment choice for standard medical care, particularly for minimizing penile curvature (3).
On the other hand, contemporary therapeutic recommendations state that the standard of care for males who initially appear with Parkinson's disease is medicinal treatment alternatives, such as oral or intralesional injectable therapy (8).
Other non-surgical treatment techniques, such as topical therapy, extracorporeal shockwave therapy, iontophoresis, and penile traction therapy (PTT), have also been employed by various writers in addition to oral and intralesional injection therapy (1-4).
Comments